Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Retinal Cell Damage in Diabetic Retinopathy
Jing Zhou,
Bo Chen
Icahn School of Medicine at Mount Sinai
Institute for Regenerative Medicine
Black Family Stem Cell Institute
Eye and Vision Research Institute
Friedman Brain Institute
Ophthalmology
Research output
:
Contribution to journal
›
Review article
›
peer-review
20
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Retinal Cell Damage in Diabetic Retinopathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Diabetic Retinopathy
100%
Cell Damage
100%
Retinal Cells
100%
Vascular Complications
27%
Retinal Neurons
27%
Neurodegeneration
18%
Early Detection
9%
Visual Loss
9%
Vascular Pathology
9%
Neuronal Dysfunction
9%
Type 1 Diabetes Mellitus (T1DM)
9%
Structural Change
9%
Functional Change
9%
Retinal Degeneration
9%
New Therapeutic Strategies
9%
Blindness
9%
Glial Cells
9%
Non-diabetic Population
9%
On-state Current
9%
Vision Loss
9%
Timely Treatment
9%
Neuron Cells
9%
Retinal Microvasculature
9%
Working Adults
9%
Vascular Manifestations
9%
Clinic Therapy
9%
Medicine and Dentistry
Cell Damage
100%
Diabetic Retinopathy
100%
Microvascular Complication
27%
Retinal Neuron
27%
Visual Impairment
18%
Neurodegeneration
18%
Prevalence
9%
Vascular Disease
9%
Diabetes Mellitus
9%
Microglia
9%
Nerve Cell Degeneration
9%
Neuroscience
Cell Damage
100%
Diabetic Retinopathy
100%
Retinal Neuron
27%
Neurodegeneration
18%
Microglia
9%
Vascular Disease
9%
Diabetes Mellitus
9%
Nerve Cell Degeneration
9%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Retinopathy
100%
Nerve Degeneration
18%
Visual Impairment
18%
Prevalence
9%
Vascular Disease
9%
Diabetes Mellitus
9%
Nerve Cell Degeneration
9%